Trial NCT02169284

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2014-01320
Secondary IDs: CO12336 HHSN261201200033I N01-CN-2012-00033 N01CN00033 NCI-2014-01320 P30CA014520 UWI2013-01-02

Last trial update was posted on 2020-07-07

MeSH Interventions

Erlotinib Hydrochloride

MeSH Conditions

Carcinoma Urinary Bladder Neoplasms

Other Conditions

Bladder Carcinoma Recurrent Bladder Carcinoma

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID